TrueBlue, Inc. (TBI) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 5 recommend buying, 4 recommend holding, and 1 recommend selling.
The analyst consensus price target for TBI is $5.75, representing a +52.9% upside from the current price of $3.76. Price targets range from a low of $5.50 to a high of $6.00.
